Court clears path Purdue Pharma opioid settlement, confirming the $7.5B plan and enabling victim compensation and company reorganization.
Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, under a new deal that was formally approved by ...
NEW YORK — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money ...
OxyContin manufacturer Purdue Pharma won court approval for an opioid-related settlement plan of at least $7.4 billion, clearing its path to exit from a six-year bankruptcy and resolve mass lawsuits ...
A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...
Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, in a new deal formally approved by a federal ...
WHITE PLAINS, N.Y.(AP) — Judge formally approves Purdue Pharma opioid settlement, with Sacklers paying up to $7B and some funds going to victims.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results